COHANCE LIFESCIENCES LTD | Large-cap | Healthcare
₹904.75
2.64%
| COHANCE LIFESCIENCES Stock Comparison:
COHANCE LIFESCIENCES vs Sun PharmaceuticalCOHANCE LIFESCIENCES vs Divi's LaboratoriesCOHANCE LIFESCIENCES vs TorrentCOHANCE LIFESCIENCES vs CiplaCOHANCE LIFESCIENCES vs Dr. Reddy'sCOHANCE LIFESCIENCES vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 5.5B
Gross Profit 4.0B 73.03%
Operating Income 668.7M 12.17%
Net Income 464.0M 8.45%
EPS (Diluted) ₹1.27

Balance Sheet Metrics

Total Assets 30.3B
Total Liabilities 11.9B
Shareholders Equity 18.4B
Debt to Equity 0.65

Cash Flow Metrics

Revenue & Profitability Trend

COHANCE LIFESCIENCES Income Statement From 2024 to 2025

Metric 2025 2024
Revenue i 11.7B 10.4B
Cost of Goods Sold i 3.1B 4.5B
Gross Profit i 8.7B 5.9B
Gross Margin % i 73.8% 56.7%
Operating Expenses
Research & Development i - -
Selling, General & Administrative i 450.4M 295.2M
Other Operating Expenses i 1.9B 271.4M
Total Operating Expenses i 2.3B 566.6M
Operating Income i 3.3B 3.5B
Operating Margin % i 28.0% 34.3%
Non-Operating Items
Interest Income i 12.7M 20.2M
Interest Expense i 114.8M 74.5M
Other Non-Operating Income - -
Pre-tax Income i 3.4B 4.1B
Income Tax i 791.5M 1.1B
Effective Tax Rate % i 23.0% 26.0%
Net Income i 2.6B 3.0B
Net Margin % i 22.6% 29.0%
Key Metrics
EBITDA i 4.2B 4.2B
EPS (Basic) i ₹10.52 ₹11.80
EPS (Diluted) i ₹10.45 ₹11.80
Basic Shares Outstanding i 254564956 254564956
Diluted Shares Outstanding i 254564956 254564956

Income Statement Trend

COHANCE LIFESCIENCES Balance Sheet From 2024 to 2025

Metric 2025 2024
Assets
Current Assets
Cash & Equivalents i 854.0M 472.3M
Short-term Investments i 1.9B 7.7B
Accounts Receivable i 2.8B 1.3B
Inventory i 1.7B 2.3B
Other Current Assets 1.1B 1.0K
Total Current Assets i 8.9B 12.6B
Non-Current Assets
Property, Plant & Equipment i 10.0B 937.1M
Goodwill i 13.7B 1.2B
Intangible Assets i 638.9M 16.7M
Long-term Investments 31.7M -
Other Non-Current Assets 5.2M -3.0K
Total Non-Current Assets i 21.4B 9.9B
Total Assets i 30.3B 22.5B
Liabilities
Current Liabilities
Accounts Payable i 802.1M 423.6M
Short-term Debt i 1.0B 437.6M
Current Portion of Long-term Debt - -
Other Current Liabilities 49.1M 65.1M
Total Current Liabilities i 3.7B 1.1B
Non-Current Liabilities
Long-term Debt i 1.8B 212.4M
Deferred Tax Liabilities i 909.8M 647.9M
Other Non-Current Liabilities - 1.0K
Total Non-Current Liabilities i 8.3B 965.3M
Total Liabilities i 11.9B 2.0B
Equity
Common Stock i 254.6M 254.6M
Retained Earnings i 13.8B 17.7B
Treasury Stock i - -
Other Equity - -
Total Shareholders Equity i 18.4B 20.5B
Key Metrics
Total Debt i 2.8B 650.0M
Working Capital i 5.2B 11.6B

Balance Sheet Composition

COHANCE LIFESCIENCES Cash Flow Statement From 2024 to 2025

Metric 2025 2024
Operating Activities
Net Income i 3.4B 4.1B
Depreciation & Amortization i - -
Stock-Based Compensation i 149.1M 19.7M
Working Capital Changes i -738.4M 729.9M
Operating Cash Flow i 2.9B 4.9B
Investing Activities
Capital Expenditures i -1.6B -517.9M
Acquisitions i -7.3B -
Investment Purchases i -3.5B -3.1B
Investment Sales i 9.8B 11.1M
Investing Cash Flow i -2.6B -3.6B
Financing Activities
Share Repurchases i - -
Dividends Paid i - -
Debt Issuance i - -
Debt Repayment i -18.5M -
Financing Cash Flow i 227.9M -270.4M
Free Cash Flow i 1.3B 3.1B
Net Change in Cash i 622.0M 949.1M

Cash Flow Trend

COHANCE LIFESCIENCES Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 89.48
Forward P/E 40.42
Price to Book 13.05
Price to Sales 26.43
PEG Ratio -1.93

Profitability Ratios

Profit Margin 19.17%
Operating Margin 12.17%
Return on Equity 14.55%
Return on Assets 8.84%

Financial Health

Current Ratio 2.43
Debt to Equity 15.16
Beta 0.64

Per Share Data

EPS (TTM) ₹9.72
Book Value per Share ₹66.64
Revenue per Share ₹49.38

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
cohance 331.5B 89.48 13.05 14.55% 19.17% 15.16
Sun Pharmaceutical 4.0T 37.84 5.44 15.08% 19.29% 3.26
Divi's Laboratories 1.7T 70.61 10.85 14.64% 23.89% 0.03
Torrent 1.2T 59.70 15.77 25.18% 16.92% 42.81
Cipla 1.2T 22.68 3.92 16.85% 19.62% 1.40
Dr. Reddy's 1.0T 18.11 2.94 17.71% 16.99% 13.75

Financial data is updated regularly. All figures are in the company's reporting currency.